| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. | Arch Neurol | 2011 | 2.81 |
| 2 | Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. | Lancet Neurol | 2012 | 2.65 |
| 3 | Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. | Neurobiol Aging | 2012 | 1.49 |
| 4 | Genetic susceptibility for Alzheimer disease neuritic plaque pathology. | JAMA Neurol | 2013 | 1.25 |
| 5 | Clinical and multimodal biomarker correlates of ADNI neuropathological findings. | Acta Neuropathol Commun | 2013 | 1.15 |